Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H (2502) AI Stock Analysis

• Market Cap: N/A
• Dividend Yield: 4.39%
• Average Volume (3M): 88.73K
• Price to Earnings (P/E): 7.3
• Beta (1Y): 0.28
• Revenue Growth: 30.77%
• EPS Growth: -128.09%
• Country: HK
• Employees: 402
• Sector: General
• Sector Strength: N/A
• Industry: Chemicals - Specialty
• EPS (TTM): N/A
• Shares Outstanding: 955,640,000
• 10 Day Avg. Volume: 72,600
• 30 Day Avg. Volume: 88,733
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: HK$0.50
• Price Target Upside: -1.96% Downside
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 61 Neutral
• Price Target: HK$0.50 ▼(-1.96% Downside)

The overall stock score is primarily influenced by the mixed financial performance, with strong revenue growth but weak profitability. Positive technical indicators provide a bullish outlook, while the valuation is negatively impacted by the company's unprofitability despite a high dividend yield.

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H Business Overview & Revenue Model

Company Description

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H (2502) is a company engaged in the production and distribution of chemical products. The company specializes in hydrogenated chemicals, offering a range of products that serve various industrial applications. With a focus on quality and innovation, Henan Jinyuan supplies its products to both domestic and international markets, catering to industries such as pharmaceuticals, agrochemicals, and more.

How the Company Makes Money

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. generates revenue primarily through the sale of its hydrogenated chemical products. The company's key revenue streams include direct sales to industrial clients in sectors like pharmaceuticals and agrochemicals, as well as distribution partnerships that help expand its market reach. Additionally, Henan Jinyuan may engage in strategic collaborations or joint ventures to enhance its product offerings and access new markets, thereby contributing to its earnings.

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H Financial Statement Overview

Summary

The company is struggling with profitability and growth consistency. Despite some revenue recovery, profitability margins have worsened, leading to net losses. The balance sheet shows moderate stability but with increased leverage, and cash flow management has improved but remains inconsistent.

Income Statement

The company has experienced significant volatility in revenue and profitability. The gross profit margin has declined from 12.4% in 2021 to 2.3% in 2024, indicating pressure on cost management. The net profit margin has deteriorated from 4.1% to negative, reflecting net losses in 2024. Revenue growth has been inconsistent, with a decrease of 10.4% from 2022 to 2023, followed by a 33.1% increase in 2024, but this did not translate to profitability. EBIT and EBITDA margins have also fallen, indicating operational inefficiencies.

Balance Sheet

The balance sheet shows moderate financial stability with a debt-to-equity ratio of 0.34 in 2024, up from 0.22 in 2020, indicating increased leverage. The return on equity has turned negative in 2024, reflecting net losses. However, the equity ratio remains strong at 58.8% in 2024, suggesting a solid asset base supported by equity.

Cash Flow

Cash flow performance has been mixed. Free cash flow turned positive in 2024, but overall growth has been inconsistent. The operating cash flow to net income ratio shows cash generation issues with net income losses. The free cash flow to net income ratio improved in 2024, indicating better cash management despite net losses.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	3.10B	2.33B	2.30B	1.46B	1.02B
Gross Profit	71.64M	148.80M	285.51M	142.80M	91.41M
EBITDA	77.03M	163.47M	266.82M	176.34M	113.14M
Net Income	-16.04M	54.92M	121.38M	59.14M	24.48M
Balance Sheet
Total Assets	1.68B	1.66B	1.06B	971.94M	969.90M
Cash, Cash Equivalents and Short-Term Investments	352.62M	300.71M	106.16M	73.03M	78.34M
Total Debt	338.27M	262.97M	219.16M	96.89M	125.83M
Total Liabilities	584.85M	535.95M	334.98M	400.14M	447.76M
Stockholders Equity	985.37M	1.02B	573.79M	457.93M	400.56M
Cash Flow
Free Cash Flow	13.82M	-43.95M	199.74M	44.27M	-21.69M
Operating Cash Flow	96.86M	104.46M	318.82M	94.88M	50.62M
Investing Cash Flow	-268.86M	-71.06M	-150.12M	-59.21M	-72.31M
Financing Cash Flow	2.49M	204.95M	-133.45M	-40.95M	20.11M

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.51
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2502, the sentiment is Positive. The current price of 0.51 is below the 20-day moving average (MA) of 0.51, above the 50-day MA of 0.48, and above the 200-day MA of 0.43, indicating a neutral trend. The MACD of <0.01 indicates Positive momentum. The RSI at 55.60 is Neutral, neither overbought nor oversold. The STOCH value of 58.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:2502.

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
2502	61 Neutral		7.33	-1.60%	4.39%	30.77%	-128.09%
Sector *	56 Neutral	$6.56B	-0.98	0.45%	6.27%	14.92%	10.98%
YIPCF	―	$128.64M	6.95	3.36%	8.86%	―	―
2116	68 Neutral	HK$213.60M	14.08	6.12%	2.25%	-4.13%	-35.11%
0301	57 Neutral	HK$606.89M	―	-8.95%	―	-3.09%	-480.17%
1986	53 Neutral	HK$771.20M	55.38	-1.16%	7.54%	2.49%	-171.78%
0377	48 Neutral	HK$86.16M	―		―	-60.57%	53.71%

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H Corporate Events

Henan Jinyuan Approves AGM Resolutions, No Final Dividend for 2024

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. announced the successful approval of all resolutions at its annual general meeting held on May 21, 2025. The resolutions included the approval of the company’s financial reports, profit distribution plan, and the appointment of Deloitte Touche Tohmatsu as auditors. Notably, the company decided not to distribute a final dividend for the year ended December 31, 2024, which may impact shareholder returns.